Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines

Keeping Current CME

English - March 27, 2023 23:43 - 34 minutes - 33.2 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: A Roadmap to Elimination: Integrating Hepatitis C Diagnosis and Management Into Everyday Primary Care

Next Episode: Clinical Updates in Hereditary Breast Cancer: Highlights From Vienna 2023

Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?

Credit available for this activity expires: 3/27/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990129?ecd=bdc_podcast_libsyn_mscpedu